Extraintestinal manifestations (EIMs) in children with inflammatory bowel disease (IBD) are associated with body mass index (BMI) in the lower or upper quartile, lower haemoglobin level, and higher C-reactive protein (CRP) level, among others, a recent study has shown.
Neither the presence nor the level of ammonia influences inpatient management of hepatic encephalopathy (HE) with lactulose, which suggests that ammonia levels do not guide therapy in clinical practice, according to a study.
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.
The use of capsule endoscopy (CE) appears to be effective in the diagnosis of iron deficiency anaemia (IDA), yielding a 33.9-percent yield in this study, with 65.8 percent of patients undergoing further workup and 12.7 percent requiring therapeutic intervention.
Both tioguanine and low‐dose thiopurines combined with allopurinol (LDTA) may be safely used in the treatment of inflammatory bowel disease (IBD) patients who have failed conventional thiopurines due to intolerance, a study has found.
The use of Janus kinase (JAK) inhibitors for the treatment of inflammatory bowel diseases (IBDs) and other immune-mediated diseases may increase the risk of herpes zoster infection, reports a recent meta-analysis.
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.